Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers
This pilot clinical trial studies how well Walking for Recovery from Surgery works in improving quality of life in older adults with lung or gastrointestinal cancer and their family caregivers. A walking program, such as Walking for Recovery from Surgery may help support overall well-being as a caregiver, and may help improve family member or friend's recovery from surgery.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
Plus 1 other study approaches.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Jun 22, 2025 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- City of Hope Medical Center
- Interventions being studied
- Behavioral: Exercise Intervention; Other: Quality-of-Life Assessment; Other: Survey Administration
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Inclusion:
- PATIENT: Diagnosis of lung or GI (colorectal, pancreas, liver) cancers
- PATIENT: Scheduled to undergo surgery
- PATIENT: \>= 65 years
- PATIENT: Able to read and understand English
- CAREGIVER: Family member/friend identified by the patient as the primary caregiver before and after surgery
- CAREGIVER: \>= 21 years
- CAREGIVER: Able to read and understand English
- This study will be conducted in patients and family caregivers who are scheduled to undergo lung or GI cancer surgery treatment
- There are no restrictions related to performance status or life expectancy
- All subjects must have the ability to understand and the willingness to sign a written informed consent Exclusion
- Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- City of Hope Medical CenterDuarte, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 22, 2025. Always confirm current availability with the study team.